December 2002
Volume 43, Issue 13
Free
ARVO Annual Meeting Abstract  |   December 2002
Time Course of Retinal Dysfunction Following Verteporfin PDT in Rats: An Electroretinography (ERG), NaF Angiography and Optical Coherence Tomography (OCT) Study
Author Affiliations & Notes
  • K Zhang
    Biological Sciences Allergan Inc Irvine CA
  • T Lin
    Biological Sciences Allergan Inc Irvine CA
  • W Ho
    Biological Sciences Allergan Inc Irvine CA
  • G DeVries
    Biological Sciences Allergan Inc Irvine CA
  • L Wheeler
    Biological Sciences Allergan Inc Irvine CA
  • J Burke
    Biological Sciences Allergan Inc Irvine CA
  • Footnotes
    Commercial Relationships    K. Zhang, Allergan, Inc E; T. Lin, Allergan, Inc. E; W. Ho, Allergan, Inc. E; G. DeVries, Allergan, Inc. E; L. Wheeler, Allergan, Inc. E; J. Burke, Allergan, Inc. E.
Investigative Ophthalmology & Visual Science December 2002, Vol.43, 2823. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      K Zhang, T Lin, W Ho, G DeVries, L Wheeler, J Burke; Time Course of Retinal Dysfunction Following Verteporfin PDT in Rats: An Electroretinography (ERG), NaF Angiography and Optical Coherence Tomography (OCT) Study . Invest. Ophthalmol. Vis. Sci. 2002;43(13):2823.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose:To evaluate the effects of Verteporfin PDT on retinal function in the normal rat. Methods:Brown Norway rats weighing 250-300 grams were used. Animals were anesthetized with 12 mg /100 g tribromoethanol ip for each procedure. Verteporfin PDT: A bolus injection of verteporfin was administered into a cannulated femoral vein at 0.2 mg/kg (equivalent to the clinical dose by body weight). Five minutes following dye administration, the right eye was irradiated with a 689 nm diode laser at 50 J/cm2, 600 mW/cm2 and a spot size of 4 mm (at the cornea) centered on the optic nerve head. ERG: Rats were dark-adapted for 15 minutes, connected to bilateral cornea electrodes and stimulated using a LKC Ganzfeld electrophysiology system, and followed-up (FU) at 4 hours, and Days 1, 2 and 5 post-PDT. OCT: Horizontal scans were made across the optic nerve and retinal thickness measurements were assessed on either side of the nerve head and averaged using a Zeiss Humphrey OCT II system; FU was at 4 hours, and Days 2 and 6 post-PDT. NaF angiography: A Zeiss FF 450 IR fundus camera was used to image the retina following an iv injection of 0.2ml of 1% NaF; FU was at 4 hours, and Days 2 and 6 post-PDT. Results:At 4 hours post-PDT, verteporfin reduced ERG A-wave and B-wave amplitudes 20 ± 9% and 25 ± 6%, respectively. Peak responses were at Day 1: A and B-waves were reduced 23 ± 9% and 41 ± 4%, respectively. At Day 5, responses were still reduced ∼ 20%. Retinal thickness increased 25 ± 3%, 13 ± 5% and 4 ± 2% at 4 hours, Days 2 and 6, respectively. NaF angiography showed occlusion of choroid only; retinal vessels remained open. Analysis showed that out of a possible maximum of 12.6 mm2, the hypofluorescence areas were 6.8 ± 1, 7.7 ± 0.2 and 7.4 ± 0.7 mm2 at 4 hours, Days 2 and 6, respectively (normal = 2.7 ± 0.7 mm2). Conclusion:Verteporfin PDT produced transient edema and persistent choroidal occlusion and ERG deficits in the normal rat retina.

Keywords: 516 photodynamic therapy • 316 animal model • 432 imaging methods (CT, FA, ICG, MRI, OCT, RTA, SLO, ultrasound) 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×